34 results found.

Bladder Cancer Clinical Trial using cisplatin; fluorouracil; mitomycin C

Radiation Therapy Oncology Group - Recruiting 18 years or older.
- A Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging.
cisplatin; fluorouracil; mitomycin C

Bladder Cancer Clinical Trial using Computed Tomography Urography (CTU); Intravenous Urography (IVU)

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Pilot Study Assessing the Technical Efficacy of Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) With Particular Focus on Patients at Risk of Urothelial Tumors.
Computed Tomography Urography (CTU); Intravenous Urography (IVU)

Bladder Cancer Clinical Trial using Collect Blood and Survey Instruments

UNC Lineberger Comprehensive Cancer Center - Recruiting 18 years or older.
- PORCH: A Registry of Prospective Outcomes of Radical Cystectomy With or Without Chemotherapy.
Collect Blood and Survey Instruments

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of th Clinical Trial using eribulin mesylate; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I/II Study of E7389 Halichondrin B Analog (NSC # 707389) in Metastatic Urothelial Tract Cancer and Renal Insufficiency.
eribulin mesylate; laboratory biomarker analysis; pharmacological study

Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasm Clinical Trial using Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine.
Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

Bladder Cancer, or Urothelial Carcinoma Clinical Trial using OGX-427; Docetaxel

Hoosier Oncology Group - Recruiting 18 years or older.
- The Borealis-2 Clinical Trial: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination With OGX-427 in Patients With Relapsed or Refractory Metastatic Urothelial Carcinoma After Receiving a Platinum-containing Regimen: Hoosier Oncology Group GU12-160.
OGX-427; Docetaxel

Bladder Cancer Clinical Trial using Dovitinib

Hoosier Oncology Group - Recruiting 18 years or older.
- A Phase II Trial of Dovitinib in Bacillus Calmette-Guerin(BCG) Refractory Urothelial Carcinoma Patients With Tumor Fibroblast Growth Factor Receptor 3(FGFR3) Mutations or Over-expression: Hoosier Oncology Group GU12-157.
Dovitinib

Bladder Cancer Clinical Trial using HS-410; Placebo

Heat Biologics - Recruiting 18 years or older.
- A Phase 1/2, Placebo-Controlled, Randomized Study to Evaluate the Safety, Immune Response and Clinical Activity of HS-410 in Patients With High-Risk Non-Muscle Invasive Bladder Cancer Who Have Undergone TURBT and Received Prior Treatment With Induction BCG.
HS-410; Placebo

Bladder Cancer Clinical Trial using Sample Collection

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- Biomarker Identification for Bladder Cancer Patients.
Sample Collection

Bladder Cancer Clinical Trial using Everolimus and Intravesical Gemcitabine

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase I/II Study of RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder.
Everolimus and Intravesical Gemcitabine

Bladder Cancer Clinical Trial using Tranexamic Acid; Placebo

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- Tranexamic Acid During Cystectomy Trial (TACT) Pilot Study.
Tranexamic Acid; Placebo

Bladder Cancer Clinical Trial using Gemcitabine; Carboplatin; Panitumumab; radical cystectomy

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.
Gemcitabine; Carboplatin; Panitumumab; radical cystectomy

Bladder Cancer Clinical Trial using MRI/acetate-PET imaging

Turku University Hospital - Recruiting 18 years to 85 years.
- PET/MRI and Biomarkers in Clinical Staging of Bladder Cancer and in the Estimation of Neoadjuvant Chemotherapy Response Prior to Radical Cystectomy.
MRI/acetate-PET imaging

Bladder Cancer Clinical Trial using white light TUR-BT; blue light TUR-BT; optimized MMC; single immediate chemotherapy instillation

Turku University Hospital - Recruiting 18 years or older.
- Treatment of Ta Bladder Cancer in High Risk of Recurrence - Fluorescence Cystoscopy With Optimized Adjuvant Mitomycin-C (FinnBladder 9).
white light TUR-BT; blue light TUR-BT; optimized MMC; single immediate chemotherapy instillation

Bladder Cancer Clinical Trial

University of Michigan - Recruiting 65 years or older.
- .

Bladder Cancer Clinical Trial using TICE Bacillus Calmette-Guerin (BCG); PANVAC

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus Calmette-Guerin (BCG) Given in Combination With PANVAC[TM] Versus BCG Given Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer (NMIBC) Who Failed at Least 1 Induction Course of BCG.
TICE Bacillus Calmette-Guerin (BCG); PANVAC

Breast Cancer, Colon Cancer, or Bladder Cancer Clinical Trial using Glycosylated Recombinant Human Interleukin-7; Diphtheria-Tetanus Vaccine; Polio Vaccine; Pneumaococcal Vaccine; Hepatitis A Vaccine; Hepatitis B Vaccine; Influenza Vaccine; PhiX 174

National Institutes of Health Clinical Center (CC) - Recruiting 60 years or older.
- A Multicenter Phase II Study of Enhancement of Immune Reconstitution and Vaccine Responses With Administration of Glyco-Recombinant Human IL-7 in Older Subjects Following Chemotherapy.
Glycosylated Recombinant Human Interleukin-7; Diphtheria-Tetanus Vaccine; Polio Vaccine; Pneumaococcal Vaccine; Hepatitis A Vaccine; Hepatitis B Vaccine; Influenza Vaccine; PhiX 174

Non-muscle Invasive Bladder Cancer Clinical Trial using ALT-801; Gemcitabine

Altor Bioscience Corporation - Recruiting 18 years or older.
- A Phase Ib/II Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-muscle Invasive Bladder Cancer.
ALT-801; Gemcitabine

Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Ca Clinical Trial using Cisplatin; Gemcitabine; ALT-801

Altor Bioscience Corporation - Recruiting 18 years or older.
- A Phase Ib/II Trial of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer.
Cisplatin; Gemcitabine; ALT-801

Bladder Cancer Clinical Trial using quality-of-life assessment; questionnaire administration

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [QOL].
quality-of-life assessment; questionnaire administration

Bladder Cancer Clinical Trial using selenium; vitamin E; chemoprevention

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [TREATMENT].
selenium; vitamin E; chemoprevention

Bladder Cancer Clinical Trial using medical chart review; questionnaire administration; study of socioeconomic and demographic variables

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [COHORT].
medical chart review; questionnaire administration; study of socioeconomic and demographic variables

Bladder Cancer Clinical Trial using bacilli calmette-guerin (BCG); lenalidomide

H. Lee Moffitt Cancer Center and Research Institute - Recruiting 18 years or older.
- Immune Modulation by Addition of Oral Lenalidomide to Intravesical BCG (Bacille Calmette-Guerrin) for Therapy of Non-muscle-invasive Transitional Cell Bladder Cancer.
bacilli calmette-guerin (BCG); lenalidomide

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of th Clinical Trial using gemcitabine hydrochloride; cisplatin; placebo; bevacizumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma.
gemcitabine hydrochloride; cisplatin; placebo; bevacizumab; laboratory biomarker analysis

Bladder Cancer Clinical Trial using external radiation therapy with gemcitabine

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy.
external radiation therapy with gemcitabine

Bladder Cancer Clinical Trial using Gemcitabine and Pazopanib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of Gemcitabine and Pazopanib in Chemotherapy Na‹ve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy.
Gemcitabine and Pazopanib

Urothelial Cancer, Renal Pelvis Cancer, Ureter Cancer, or Bladder Clinical Trial using saliva sample and questionaire; saliva sample, questionaire

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Familial and Atypical Urothelial Cancer Registry.
saliva sample and questionaire; saliva sample, questionaire

Bladder Cancer Clinical Trial using cisplatin; fluorouracil; gemcitabine hydrochloride; radiation therapy

Radiation Therapy Oncology Group - Recruiting 18 years or older.
- A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy.
cisplatin; fluorouracil; gemcitabine hydrochloride; radiation therapy

Bladder Cancer, Cancer, Bladder Neoplasms, or Urinary Bladder Can Clinical Trial

Lahey Clinic - Recruiting 18 years or older.
- Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer.

Bladder Cancer Clinical Trial using sample collection; Sample Collection

Christie Hospital NHS Foundation Trust - Recruiting 18 years or older.
- Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy.
sample collection; Sample Collection

Bladder Cancer Clinical Trial using lapatinib ditosylate; Placebo

Queen Mary University of London - Recruiting 18 years or older.
- A Phase II/III, Randomised, Two-Arm, Comparison of Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With HER1 and/or HER2 Overexpressing Locally Advanced or Metastatic Bladder Cancer [LaMB].
lapatinib ditosylate; Placebo

Bladder Cancer, or Prostate Cancer Clinical Trial using Multiphoton microscopy

Weill Medical College of Cornell University - Recruiting 21 years to 85 years.
- Use of Multiphoton Microscopy in the Diagnosis of Cancer.
Multiphoton microscopy

Superficial Transitional Cell Carcinoma Therapy, or (NMIBC = Non Clinical Trial using Synergo; BCG

Medical Enterprises Europe B.V. - Recruiting 18 years or older.
- A Randomized Controlled Study Comparing Adjuvant Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG Immunotherapy (BCG) Adjuvant Treatment in Patients With Superficial Transitional Cell Carcinoma of the Bladder (STCCB).
Synergo; BCG

Bladder Cancer Clinical Trial using cisplatin; specimen ultra-high-field magnetic resonance imaging; 3-Tesla magnetic resonance imaging; diffusion-weighted magnetic resonance imaging; dynamic contrast-enhanced magnetic resonance imaging; functional magnetic resonance imaging; magnetic resonance spectroscopic imaging; neoadjuvant therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Imaging of Bladder Cancer Using Clinical 3 Tesla MRI and EX-VIVO Ultra-High-Field MRI..
cisplatin; specimen ultra-high-field magnetic resonance imaging; 3-Tesla magnetic resonance imaging; diffusion-weighted magnetic resonance imaging; dynamic contrast-enhanced magnetic resonance imaging; functional magnetic resonance imaging; magnetic resonance spectroscopic imaging; neoadjuvant therapy